Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.
2.

India's growing participation in global clinical trials.

Gupta YK, Padhy BM.

Trends Pharmacol Sci. 2011 Jun;32(6):327-9. doi: 10.1016/j.tips.2011.02.017. Epub 2011 Apr 12.

PMID:
21489644
3.

Emerging trends in contract research industry in India.

Drabu S, Gupta A, Bhadauria A.

Contemp Clin Trials. 2010 Sep;31(5):419-22. doi: 10.1016/j.cct.2010.06.008. Epub 2010 Jul 4. Review.

PMID:
20609394
4.

India's pharmaceutical industry: hype or high tech take-off?

Malhotra P, Lofgren H.

Aust Health Rev. 2004 Nov 8;28(2):182-93.

PMID:
15527398
5.

Brazil: An emerging partner in drug R&D.

Rodrigues DG.

IDrugs. 2009 Aug;12(8):497-502. Review.

PMID:
19629884
6.
7.

Entering the contract research industry in India.

Joseph J.

Contemp Clin Trials. 2008 May;29(3):311-3. Epub 2007 Nov 6.

PMID:
18053773
8.

Boom in clinical research industry: a dangerous trend.

Bajpai V, Saraya A.

Trop Gastroenterol. 2009 Jul-Sep;30(3):177-81.

PMID:
20306757
9.

Indian pharma enters the global arena.

Singh S.

Cell. 2007 Mar 9;128(5):811-4.

10.

The Indian and Chinese health biotechnology industries: potential champions of global health?

Frew SE, Kettler HE, Singer PA.

Health Aff (Millwood). 2008 Jul-Aug;27(4):1029-41. doi: 10.1377/hlthaff.27.4.1029.

11.

India's drug tests.

Padma TV.

Nature. 2005 Jul 28;436(7050):485. No abstract available.

PMID:
16049471
12.

Clinical trials in India.

Maiti R, M R.

Pharmacol Res. 2007 Jul;56(1):1-10. Epub 2007 Feb 20. Review.

PMID:
17391981
13.

Audits of clinical trials in India: a step in the right direction.

Roychowdhury V.

J Biolaw Bus. 2006;9(3):26-8.

PMID:
17152136
14.

Developing new products in cystic fibrosis: needs and obstacles for activities of small and middle-sized companies.

Schlangen M, Reimann AL.

J Cyst Fibros. 2011 Jun;10 Suppl 2:S103-9. doi: 10.1016/S1569-1993(11)60015-5.

15.

[Contact and dialogue between drug companies and the global regulatory authorities throughout research and development phase].

Kock M, Thomsen MK.

Ugeskr Laeger. 2003 Apr 14;165(16):1649-52. Review. Danish.

PMID:
12756820
16.

Toxicologic pathology in a multicultural world--India.

Schultze AE, Reddy VR, Donnelly KB, Berridge BR.

Toxicol Pathol. 2011 Oct;39(6):1003-9. doi: 10.1177/0192623311414734. Epub 2011 Aug 22.

PMID:
21859882
17.

Clinical trials and contract research organizations in India.

Mukherjee S.

Clin Lab Med. 2012 Jun;32(2):315-20. doi: 10.1016/j.cll.2012.04.008. Epub 2012 May 17. Review.

PMID:
22727008
18.

Medical needs of cystic fibrosis patients and policies for fair co-operation between small and middle-sized companies and patient organizations.

Schlangen M, Reimann AL.

J Cyst Fibros. 2011 Jun;10 Suppl 2:S110-3. doi: 10.1016/S1569-1993(11)60016-7.

19.

Towards a European Clinical Research Infrastructures Network: the ECRIN programme.

Demotes-Mainard J.

Therapie. 2004 Jan-Feb;59(1):151-3.

PMID:
15199684
20.

Integrating worldwide marketing needs and clinical research.

Kaniecki DJ, Arnold RJ.

J Clin Pharmacol. 1993 Oct;33(10):989-92. Review.

PMID:
8227471

Supplemental Content

Support Center